CBI Arrests CBN Inspector, Middleman For Taking Rs 3 Lakh Bribe In Rajasthan

Chittorgarh:  The Central Bureau of Investigation (CBI) has arrested an inspector of the Central Narcotics Bureau (CBN) of Chittorgarh and a middleman while taking bribe. A bribe of Rs 20 lakh was demanded to settle a case against a clinic. The accused inspector has been caught taking a bribe of Rs 3 lakh through a middleman. At present, the CBI team is busy interrogating both the accused.(Video)

The complainant filed a complaint with the Central Bureau of Investigation (CBI). In this, the inspector of the Central Narcotics Bureau (CBN) of Chittorgarh is demanding a bribe of Rs 3 lakh through a middleman. The bribe amount is being demanded by the accused to settle the case against his clinic. A bribe of Rs 20 lakh was demanded to settle the case. After that, a bribe of Rs 8 lakh was demanded by the accused.

On the complaint, a case was registered on Wednesday against the accused Inspector Adarsh ​​Yogi of the Central Narcotics Bureau and middleman Keshav. Then the CBI laid a trap and caught the middleman Keshav red-handed while taking a bribe of Rs 3 lakh from Chittorgarh NCB Inspector Adarsh ​​Yogi. During the search, the team also found many objectionable documents, which were seized by the CBI. At present, the CBI team is busy interrogating both the accused.

Related Posts

  • Pharma
  • March 20, 2025
  • 46 views
Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

A research paper published on Patanjali’s Renogrit, a formulation that is effective against cancer drug cisplatin’s damaging effect on kidneys, has been featured among the most notable research studies of 2024.…

  • Pharma
  • March 19, 2025
  • 123 views
Strides Pharma approves demerger from Arco Labs

Strides Pharma is set to demerge from Arco Labs, a global capability centre, the company said in its exchange filing on Wednesday. Board of Directors of Strides Pharma Science Limited (Strides) and Arco…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers

Strides Pharma approves demerger from Arco Labs

Strides Pharma approves demerger from Arco Labs

Milestone Pharma Expands Sale Agreement, Increases Offering

Milestone Pharma Expands Sale Agreement, Increases Offering

Novo Nordisk regains membership in UK pharma body

Novo Nordisk regains membership in UK pharma body

USV Joins Empagliflozin generic contest, launches its brand Xenia

USV Joins Empagliflozin generic contest, launches its brand Xenia

SMS Hospital revamps blood safety protocols after fatal transfusion error

SMS Hospital revamps blood safety protocols after fatal transfusion error